AstraZeneca PLC AZN
Set alert
183.99 USD -2.59 -1.39%
As of Nov 3, 12:27 PM ET
183.94 Day range 187.35
155.62 52-week range 209.48
- YTD
- +0.07%
- 1 year
- +12.57%
- Open
- 186.11
- Prev close
- 186.58
- Mkt cap
- 285.35B
- Vol
- 1.17M
- Avg vol
- 3.26M
- EPS
- 7.07
- P/E
- 26.02
- Div yield
- 1.24%
More statistics
- Low
- 183.94
- High
- 187.35
- Forward P/E
- 16.49
- Beta
- 0.17
- Short ratio
- 1.14
- Inst. own
- 76.32%
- Dividend
- 3.20
- Ex-div date
- Aug 6, 2026
- Earnings
- Feb 9, 2027
- 50-d avg
- 164.48
- 200-d avg
- 180.16
- 1y target
- 206.66
MAX chart
Events in this range
- Apr 7, 1999Dividend: 0.4956
- Sep 6, 2000Dividend: 0.2555
- Feb 7, 2007Dividend: 1.23
- Feb 7, 2008Dividend: 1.35
- Aug 6, 2008Dividend: 0.55
- Feb 4, 2009Dividend: 1.5
- Aug 5, 2009Dividend: 0.59
- Feb 3, 2010Dividend: 1.71
- Aug 4, 2010Dividend: 0.7
- Feb 2, 2011Dividend: 1.85
- Aug 4, 2011Dividend: 0.85
- Apr 2, 2014Dividend: 0
- Jun 5, 2014Dividend: 0
- Nov 6, 2025Earnings: 2.38; estimate 2.28; surprise 4.39%
- Feb 2, 2026Split: 1 for 2
- Aug 7, 2026Dividend: 1.06
Signals (153)
| Name | Date | Ago |
|---|---|---|
| SMA: Bullish | Oct 1, 2026 | 1 month ago |
| SMA: Bullish | Oct 1, 2026 | 1 month ago |
| SMA: Bearish | Sep 1, 2026 | 2 months ago |
| MACD: Sell Signal | Aug 1, 2026 | 3 months ago |
| SMA: Bearish | Jul 1, 2026 | 4 months ago |
| RSI: Overbought | Feb 1, 2026 | 9 months ago |
| MACD: Buy Signal | Oct 1, 2025 | 1 year ago |
| SMA: Bullish | Jul 1, 2025 | 1 year ago |
| SMA: Bullish | Jul 1, 2025 | 1 year ago |
| SMA: Bearish | Jun 1, 2025 | 1 year ago |
| SMA: Bearish | Mar 1, 2025 | 1 year ago |
| SMA: Bullish | Feb 1, 2025 | 1 year ago |
| SMA: Bullish | Jan 1, 2025 | 1 year ago |
| SMA: Bearish | Nov 1, 2024 | 2 years ago |
| MACD: Sell Signal | Nov 1, 2024 | 2 years ago |
| SMA: Bearish | Oct 1, 2024 | 2 years ago |
| RSI: Overbought | Aug 1, 2024 | 2 years ago |
| MACD: Buy Signal | May 1, 2024 | 2 years ago |
| SMA: Bullish | Mar 1, 2024 | 2 years ago |
| SMA: Bullish | Mar 1, 2024 | 2 years ago |
Newest 20 of 153.
Financial health
Altman Z-Score
3.65 Safe zone
Bankruptcy-risk model: below 1.81 distress, above 2.99 safe.
Piotroski F-Score
7 / 9 Strong
Nine pass/fail tests of profitability, leverage and efficiency.
FMP rating
A-4 / 5 overall
- DCF 5
- Return on Equity 5
- Return on Assets 5
- Debt / Equity 2
- P/E 2
- P/B 2
Valuation
P/E 26.6×
FY 2016 5y median 34.9× FY 2025
P/S 4.6×
FY 2016 5y median 4.5× FY 2025
P/B 5.6×
FY 2016 5y median 5.3× FY 2025
P/FCF 31.4×
FY 2016 5y median 31.4× FY 2025
EV/EBITDA 14.9×
FY 2016 5y median 17.2× FY 2025
EV/Sales 5.0×
FY 2016 5y median 5.0× FY 2025
FCF Yield 3.2%
FY 2016 5y median 3.2% FY 2025
Profitability
Gross Margin 81.9%
FY 2016 5y median 81.1% FY 2025
Operating Margin 23.4%
FY 2016 5y median 17.9% FY 2025
Net Margin 17.5%
FY 2016 5y median 13.0% FY 2025
ROE 21.1%
FY 2016 5y median 15.2% FY 2025
ROIC 13.0%
FY 2016 5y median 9.3% FY 2025
ROA 9.0%
FY 2016 5y median 5.9% FY 2025
Growth (YoY)
Revenue 8.6%
FY 2016 FY 2025
Operating Income 37.4%
FY 2016 FY 2025
EPS (diluted) 45.3%
FY 2016 FY 2025
Free Cash Flow 19.2%
FY 2016 FY 2025
Financial Health
Current Ratio 0.9×
FY 2016 5y median 0.9× FY 2025
Quick Ratio 0.7×
FY 2016 5y median 0.7× FY 2025
Debt / Equity 0.6×
FY 2016 5y median 0.7× FY 2025
Net Debt / EBITDA 1.2×
FY 2016 5y median 1.7× FY 2025
Interest Coverage 8.1×
FY 2016 5y median 5.2× FY 2025
Dividends
Dividend Yield 1.8%
FY 2016 5y median 2.2% FY 2025
Payout Ratio 48.5%
FY 2016 5y median 75.2% FY 2025
Annual · latest fiscal year ends 2025-12-31
